Previous studies have shown expression of human Tau in animal models leads to several neurodegenerative phenotypes similar to human AD cases including an increase in cell death, shrinkage in brain size and defects in cognitive ability (Wittmann et al., 2001; Gistelinck et al., 2012). Here, MAPT is linked to Alzheimer disease.